RETATRUTIDE (70mg)

Retatrutide is a next-generation triple agonist peptide that activates GLP-1, GIP, and glucagon receptors, making it one of the most extensively studied investigational peptides in metabolic research. By targeting three complementary pathways involved in appetite regulation and energy balance, Retatrutide has attracted significant interest for its potential effects on body weight and metabolic function.

Researchers are investigating Retatrutide for its potential to:

* Support appetite regulation and reduce food intake.

* Influence energy expenditure through glucagon receptor activity.

* Improve metabolic function and glucose regulation.

* Promote significant reductions in body weight within clinical research settings.

Its unique triple-receptor mechanism distinguishes Retatrutide from dual- and single-agonist peptides, making it a promising area of ongoing metabolic research.

This product is intended for research purposes only and is not approved as a medicine or treatment for any disease.